Status:
UNKNOWN
How Bone is Made in Children Receiving Dialysis
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
Children's Hospital Los Angeles
Loma Linda University
Conditions:
Bone Mineralization Defect
Eligibility:
All Genders
6-21 years
Phase:
PHASE4
Brief Summary
The study outlined is designed to measure and to determine whether the combined use of vitamin D2 (ergocalciferoI) and 1-alpha-hydroxyvitamin D2 (doxercalciferol)) or doxercalciferol alone will correc...
Eligibility Criteria
Inclusion
- medically stable patients
- 6-21 years old
- undergoing treatment with continuous cycling peritoneal dialysis
- evidence of mineralization defect and secondary hyperparathyroidism
Exclusion
- histopathological lesion of bone such as adynamic bone or osteomalacia
- poor compliance
- current treatment with prednisone or other immunosuppressives
- treatment with human recombinant growth hormone
- parathyroidectomy
Key Trial Info
Start Date :
March 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2014
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT01799317
Start Date
March 1 2009
End Date
June 1 2014
Last Update
February 26 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Loma Linda University
Loma Linda, California, United States, 92354
2
Childrens Hospital Los Angeles
Los Angeles, California, United States, 90027